Indication: Vitamin drugs. Mainly used for coagulation disorders caused by vitamin K deficiency. For example, vitamin K deficiency caused by intestinal malabsorption. Obstructive jaundice caused by various reasons, chronic ulcerative colitis, chronic pancreatitis and reduced intestinal absorption function after extensive small bowel resection; long-term use of antibiotics can lead to vitamin K deficiency in the body, broad-spectrum antibiotics or intestinal sterilization drugs can kill or inhibit the bacterial flora in the normal intestine, resulting in a decrease in the vitamins synthesized by intestinal bacteria; the molecular structure of anticoagulants such as dicoumarol is similar to that of vitamin K, which interferes with its metabolism in the body, preventing epoxyphylloquinone from being reduced to vitamin K, and preventing vitamin K in the body from playing its role, resulting in consequences similar to vitamin K deficiency.

Indication: Used to treat related diseases: including duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome, especially for ulcers with bleeding, vomiting or inability to eat, as well as refractory ulcers and acute pancreatitis. It can also be used to prevent stress ulcers caused by major surgery or severe trauma.

Indication: Used to treat related diseases: including duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome, especially for ulcers with bleeding, vomiting or inability to eat, as well as refractory ulcers and acute pancreatitis. It can also be used to prevent stress ulcers caused by major surgery or severe trauma.

Indication: Used to treat related diseases: including duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome, especially for ulcers with bleeding, vomiting or inability to eat, as well as refractory ulcers and acute pancreatitis. It can also be used to prevent stress ulcers caused by major surgery or severe trauma.

Indication: 1. Emergency treatment of esophageal-gastric varicose bleeding caused by liver cirrhosis, combined with special treatments (such as endoscopic sclerotherapy); 2. Prevention of complications after pancreatic surgery; 3. Relieve symptoms and signs related to gastrointestinal endocrine tumors. There is sufficient evidence to show that this product is effective for the following tumors: carcinoid tumors with carcinoid syndrome; VIP tumors; glucagon tumors. The efficacy of this product for the following tumors is about 50% (so far, the number of cases treated with this product is limited): gastrinoma/Zollinger-Ellison syndrome, insulinoma, growth hormone releasing factor tumor; 4. Patients with acromegaly who have failed surgery, radiotherapy or dopamine receptor agonists.

Indication: 1. Emergency treatment of esophageal-gastric varicose bleeding caused by liver cirrhosis, combined with special treatments (such as endoscopic sclerotherapy); 2. Prevention of complications after pancreatic surgery; 3. Relieve symptoms and signs related to gastrointestinal endocrine tumors. There is sufficient evidence to show that this product is effective for the following tumors: carcinoid tumors with carcinoid syndrome; VIP tumors; glucagonomas. The efficacy of this product for the following tumors is about 50% (so far, the number of cases treated with this product is limited): gastrinoma/Zollinger-Ellison syndrome, insulinoma, growth hormone releasing factor tumor; 4. It can control symptoms and reduce the concentration of growth hormone (GH) and growth hormone mediator C in patients with acromegaly who have failed surgery, radiotherapy or dopamine receptor agonists. It is also suitable for patients who are not

Indication: This product is suitable for: 1. Emergency treatment of esophageal-gastric varicose bleeding caused by liver cirrhosis, combined with special treatments (such as endoscopic sclerotherapy); 2. Prevention of complications after pancreatic surgery; 3. Relieve symptoms and signs related to gastrointestinal endocrine tumors. There is sufficient evidence to show that this product is effective for the following tumors: carcinoid tumors with carcinoid syndrome; VIP tumors; glucagon tumors. The efficacy of this product for the following tumors is about 50% (so far, the number of cases treated with this product is limited): gastrinoma/Zollinger-Ellison syndrome, insulinoma, growth hormone releasing factor tumor; 4. After surgery, radiotherapy or dopamine receptor

Indication: 1. Emergency treatment of esophageal-gastric varicose bleeding caused by liver cirrhosis, used in combination with special treatments (such as endoscopic sclerotherapy). 2. Prevention of complications after pancreatic surgery. 3. Relieve symptoms and signs related to gastrointestinal endocrine tumors. There is sufficient evidence to show that this product is effective for the following tumors: carcinoid tumors with carcinoid syndrome; VIP tumors; glucagonomas. The efficacy of this product for the following tumors is about 50% (so far, the number of cases treated with this product is limited); gastrinoma/Zollinger-Ellison syndrome, insulinoma, growth hormone releasing factor tumor. 4. It can control symptoms and reduce the concentrations of growth hormone (GH) and growth hormone mediator C in patients with acromegaly who have failed surgery, radiotherapy or dopamine receptor agonists. It is also suitable for

Indication: Digestive system medications. Esophageal gastric venous bleeding, peptic ulcer and emergency ulcer, acute pancreatitis, prevention of complications after pancreatic surgery, gastrointestinal pancreatic endocrine tumors, acromegaly.

Indication: This product is only suitable for acromegaly and some digestive tract carcinoids and neuroendocrine tumors that require long-term administration. It is not suitable for short-term treatment of acute pancreatitis, upper gastrointestinal bleeding, etc.